Richard Eastell

2.8k total citations
29 papers, 2.0k citations indexed

About

Richard Eastell is a scholar working on Orthopedics and Sports Medicine, Genetics and Oncology. According to data from OpenAlex, Richard Eastell has authored 29 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Orthopedics and Sports Medicine, 14 papers in Genetics and 13 papers in Oncology. Recurrent topics in Richard Eastell's work include Bone health and osteoporosis research (23 papers), Estrogen and related hormone effects (14 papers) and Bone health and treatments (11 papers). Richard Eastell is often cited by papers focused on Bone health and osteoporosis research (23 papers), Estrogen and related hormone effects (14 papers) and Bone health and treatments (11 papers). Richard Eastell collaborates with scholars based in United Kingdom, United States and Belgium. Richard Eastell's co-authors include Pierre D. Delmas, Kristine E. Ensrud, Catharine R. Galé, S Kellingray, Christopher Martyn, Cyrus Cooper, Dennis M. Black, Steven R. Cummings, José Zanchetta and C. Gennari and has published in prestigious journals such as New England Journal of Medicine, Circulation and The Journal of Clinical Endocrinology & Metabolism.

In The Last Decade

Richard Eastell

29 papers receiving 1.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Richard Eastell United Kingdom 18 1.0k 788 731 500 352 29 2.0k
John L. Stock United States 23 1.8k 1.7× 1.3k 1.6× 646 0.9× 940 1.9× 288 0.8× 59 2.9k
Jordi Farrerons Spain 21 975 1.0× 975 1.2× 441 0.6× 560 1.1× 340 1.0× 35 2.0k
Ho Yeon Chung South Korea 22 476 0.5× 422 0.5× 177 0.2× 518 1.0× 353 1.0× 73 1.8k
Zebulun D. Horowitz United States 11 1.7k 1.7× 1.2k 1.5× 375 0.5× 826 1.7× 451 1.3× 15 2.7k
Paul Ryan United Kingdom 20 244 0.2× 249 0.3× 271 0.4× 263 0.5× 169 0.5× 36 1.3k
Samantha L. Bowker Canada 22 145 0.1× 679 0.9× 74 0.1× 1.4k 2.8× 782 2.2× 39 2.2k
Guilin Qiao United States 20 151 0.1× 272 0.3× 78 0.1× 338 0.7× 139 0.4× 33 1.8k
Mary Anne Fallon United States 12 633 0.6× 1.2k 1.5× 183 0.3× 261 0.5× 518 1.5× 15 2.0k
Jarley Koo Canada 19 83 0.1× 1.2k 1.5× 155 0.2× 679 1.4× 199 0.6× 29 2.1k
Annette Schlemmer Denmark 13 463 0.5× 333 0.4× 153 0.2× 258 0.5× 197 0.6× 21 1.5k

Countries citing papers authored by Richard Eastell

Since Specialization
Citations

This map shows the geographic impact of Richard Eastell's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Richard Eastell with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Richard Eastell more than expected).

Fields of papers citing papers by Richard Eastell

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Richard Eastell. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Richard Eastell. The network helps show where Richard Eastell may publish in the future.

Co-authorship network of co-authors of Richard Eastell

This figure shows the co-authorship network connecting the top 25 collaborators of Richard Eastell. A scholar is included among the top collaborators of Richard Eastell based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Richard Eastell. Richard Eastell is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Black, Dennis M., et al.. (2024). Bone mineral density as a surrogate endpoint for fracture risk reduction in clinical trials of osteoporosis therapies: an update on SABRE. The Lancet Diabetes & Endocrinology. 12(6). 371–373. 6 indexed citations
2.
Eastell, Richard, David M. Reid, Slobodan Vukičević, et al.. (2012). Effects of 3 years of lasofoxifene treatment on bone turnover markers in women with postmenopausal osteoporosis. Bone. 50(5). 1135–1140. 6 indexed citations
3.
Cummings, S. R., Kristine E. Ensrud, Pierre D. Delmas, et al.. (2010). Lasofoxifene in Postmenopausal Women With Osteoporosis. Obstetrical & Gynecological Survey. 65(7). 447–448. 21 indexed citations
4.
LaCroix, Andrea Z., TJ Powles, C. Kent Osborne, et al.. (2010). Breast Cancer Incidence in the Randomized PEARL Trial of Lasofoxifene in Postmenopausal Osteoporotic Women. JNCI Journal of the National Cancer Institute. 102(22). 1706–1715. 104 indexed citations
5.
Delmas, Pierre D., F. Munoz, Dennis M. Black, et al.. (2009). Effects of Yearly Zoledronic Acid 5 mg on Bone Turnover Markers and Relation of PINP With Fracture Reduction in Postmenopausal Women With Osteoporosis. Journal of Bone and Mineral Research. 24(9). 1544–1551. 90 indexed citations
6.
Eastell, Richard, Thomas Lang, Steven Boonen, et al.. (2009). Effect of once-yearly zoledronic acid on the spine and hip as measured by quantitative computed tomography: results of the HORIZON Pivotal Fracture Trial. Osteoporosis International. 21(7). 1277–1285. 38 indexed citations
7.
Cummings, Steven R., Bruce Ettinger, Pierre D. Delmas, et al.. (2008). The Effects of Tibolone in Older Postmenopausal Women. New England Journal of Medicine. 359(7). 697–708. 292 indexed citations
8.
Rogers, Angela J., J. A. Clowes, Claudia Alejandra Pereda, & Richard Eastell. (2006). Different effects of raloxifene and estrogen on interleukin-1β and interleukin-1 receptor antagonist production using in vitro and ex vivo studies. Bone. 40(1). 105–110. 13 indexed citations
9.
Reid, Ian R., Richard Eastell, Ignac Fogelman, et al.. (2004). A Comparison of the Effects of Raloxifene and Conjugated Equine Estrogen on Bone and Lipids in Healthy Postmenopausal Women. Archives of Internal Medicine. 164(8). 871–871. 53 indexed citations
10.
Locker, Gershon Y. & Richard Eastell. (2003). The time course of bone fractures observed in the ATAC (‘Arimidex', Tamoxifen, Alone or in Combination) Trial. 22 indexed citations
11.
Black, Dennis M., Felicia Cosman, Richard Eastell, Gregory R. Mundy, & Clifford J. Rosen. (2002). Meeting report from the national osteoporosis foundation 5th international symposium on clinical advances in osteoporosis. 1 indexed citations
12.
Delmas, Pierre D., Kristine E. Ensrud, Jonathan D. Adachi, et al.. (2002). Efficacy of Raloxifene on Vertebral Fracture Risk Reduction in Postmenopausal Women with Osteoporosis: Four-Year Results from a Randomized Clinical Trial. The Journal of Clinical Endocrinology & Metabolism. 87(8). 3609–3617. 438 indexed citations
13.
Pols, H.A.P., Richard Eastell, Pierre Delmas, et al.. (2001). Early onset and sustained efficacy of raloxifene on incident vertebral fractures in postmenopausal women with ostoporosis : 4-year results from the MORE trial. Open Repository and Bibliography (University of Liège). 2 indexed citations
14.
Galé, Catharine R., Christopher Martyn, S Kellingray, Richard Eastell, & Cyrus Cooper. (2001). Intrauterine Programming of Adult Body Composition1. The Journal of Clinical Endocrinology & Metabolism. 86(1). 267–272. 257 indexed citations
15.
Eastell, Richard, Jonathan D. Adachi, Kristine D. Harper, et al.. (2000). The effects of raloxifene on incident vertebral fractures in postmenopausal women with osteoporosis : 4-year results from the MORE trial. Open Repository and Bibliography (University of Liège). 6 indexed citations
16.
Delmas, PD, Steven A. Harris, H.A.P. Pols, et al.. (1999). Raloxifene therapy for 3 years reduces the risk of incident vertebral fractures in postmenopausal women. Open Repository and Bibliography (University of Liège). 2 indexed citations
17.
Hannon, R.A., et al.. (1999). Monitoring Alendronate Therapy for Osteoporosis. Journal of Bone and Mineral Research. 14(4). 602–608. 69 indexed citations
18.
Ensrud, Kristine E., D Black, Robert R. Recker, et al.. (1998). The effect of 2 and 3 years of Raloxifene on vertebral and non-vertebral fractures in postmenopausal women with osteoporosis. Open Repository and Bibliography (University of Liège). 17 indexed citations
19.
Peel, Nicola, et al.. (1996). Rate of bone loss from lumbar spine in women with distal forearm fracture: Fig 1. BMJ. 312(7044). 1457–1457. 3 indexed citations
20.
Bell, Norman H., Bruce W. Hollis, Judith Shary, et al.. (1994). Diclofenac sodium inhibits bone resorption in postmenopausal women. The American Journal of Medicine. 96(4). 349–353. 38 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by John L. Stock Breakdown of academic impact, for papers by Jordi Farrerons Breakdown of academic impact, for papers by Ho Yeon Chung Breakdown of academic impact, for papers by Zebulun D. Horowitz Breakdown of academic impact, for papers by Paul Ryan Breakdown of academic impact, for papers by Samantha L. Bowker Breakdown of academic impact, for papers by Guilin Qiao Breakdown of academic impact, for papers by Mary Anne Fallon Breakdown of academic impact, for papers by Jarley Koo Breakdown of academic impact, for papers by Annette Schlemmer
Rankless by CCL
2026